Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: results from the Veterans Affairs Cancer of the Prostate Outcomes Study.

[1]  M. Sullivan,et al.  Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30 , 1996, Quality of Life Research.

[2]  P. Ganz,et al.  Describing the health-related quality of life impact of HIV infection: Findings from a study using the HIV Overview of Problems—Evaluation System (HOPES) , 1993, Quality of Life Research.

[3]  G. I. Ringdal,et al.  Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses , 1993, Quality of Life Research.

[4]  N. Vogelzang,et al.  Quality of life and psychosocial status in stage D prostate cancer , 1992, Quality of Life Research.

[5]  T. Wilt,et al.  Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review. , 2001, Urology.

[6]  D. Katz,et al.  Effect of Treatment on Quality of Life Among Men With Clinically Localized Prostate Cancer , 2001, Medical care.

[7]  R A Stephenson,et al.  Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. , 2000, Journal of the National Cancer Institute.

[8]  H. Fukuda,et al.  European Organization for Research and Treatment of Cancer (EORTC) and International Society for Cutaneous Lymphoma (ISCL) consensus recommendations for the management of cutaneous B-cell lymphomas Blood 2008; 112(5):1600-9 , 2022 .

[9]  R A Stephenson,et al.  Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. , 2000, JAMA.

[10]  S. Fosså,et al.  Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. , 1999, International journal of radiation oncology, biology, physics.

[11]  D. Lubeck,et al.  Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. , 1999, Urology.

[12]  O. S. Nielsen,et al.  Urinary symptoms, potency, and quality of life in patients with localized prostate cancer followed up with deferred treatment. , 1998, Urology.

[13]  L. Sharp,et al.  Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures. , 1998, The Journal of urology.

[14]  E. Crawford,et al.  Quality of life in advanced prostate cancer: results of a randomized therapeutic trial. , 1998, Journal of the National Cancer Institute.

[15]  C. Bennett,et al.  Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Yarbro Ch,et al.  Quality of life of patients with prostate cancer treated with surgery or radiation therapy. , 1998 .

[17]  J. Ware,et al.  Health-related quality of life among patients with metastatic prostate cancer. , 1997, Urology.

[18]  S. Fosså.  Quality of life in advanced prostate cancer. , 1996, Seminars in oncology.

[19]  Roach Rd.  Neoadjuvant total androgen suppression and radiotherapy in the management of locally advanced prostate cancer. , 1996 .

[20]  M. E. Smith,et al.  The Department of Veterans Affairs medical care system and the people it serves. , 1996, Medical care.

[21]  R H Brook,et al.  Quality-of-life outcomes in men treated for localized prostate cancer. , 1995, JAMA.

[22]  W. Catalona,et al.  Management of cancer of the prostate. , 1994, The New England journal of medicine.

[23]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[24]  H. Herr,et al.  A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy , 1993, Cancer.

[25]  P. Goodman,et al.  A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. , 1989, The New England journal of medicine.

[26]  W. Peeling,et al.  Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma. , 1989, Urology.

[27]  F. Barquin.  A new technique of perirenal air insufflation. , 1947, The Journal of urology.